Astal Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Interest and Dividend Income	-	-	-	-	2.11
Total Interest Expense	20.33	7.01	0.11	-	-
Net Interest Income	-20.33	-7.01	-0.11	-	2.11
Other Revenue	2,493	643.56	236.61	36.07	-
Revenue Before Loan Losses	2,473	636.55	236.5	36.07	2.11
Revenue	2,473	636.55	236.5	36.07	2.11
Revenue Growth (YoY)	288.52%	169.15%	555.71%	1611.01%	3.80%
Salaries & Employee Benefits	50.22	13.39	4.66	-	0.85
Cost of Services Provided	2,190	484.21	215.42	35.67	0.11
Other Operating Expenses	43.16	16.96	5.27	-	1.12
Total Operating Expenses	2,296	516.78	225.64	35.75	2.23
Operating Income	177.3	119.78	10.87	0.32	-0.12
EBT Excluding Unusual Items	177.3	119.78	10.87	0.32	-0.12
Pretax Income	177.3	119.78	10.87	0.32	-0.17
Income Tax Expense	30.21	30.52	3.02	0.16	0
Net Income	147.09	89.25	7.85	0.16	-0.17
Net Income to Common	147.09	89.25	7.85	0.16	-0.17
Net Income Growth	64.81%	1037.42%	4684.76%	-	-
Shares Outstanding (Basic)	31	10	5	4	4
Shares Outstanding (Diluted)	34	11	5	4	4
Shares Change (YoY)	207.54%	119.71%	27.10%	-	-
EPS (Basic)	4.76	9.08	1.55	0.04	-0.04
EPS (Diluted)	4.31	8.04	1.55	0.04	-0.04
EPS Growth	-46.41%	417.71%	3689.19%	-	-
Free Cash Flow	-190.91	-182.92	-114.96	-14.37	-2.49
Free Cash Flow Per Share	-5.59	-16.48	-22.76	-3.62	-0.63
Operating Margin	7.17%	18.82%	4.59%	0.89%	-5.74%
Profit Margin	5.95%	14.02%	3.32%	0.46%	-8.11%
Free Cash Flow Margin	-7.72%	-28.74%	-48.61%	-39.83%	-118.03%
Effective Tax Rate	17.04%	25.48%	27.78%	48.75%	-
Revenue as Reported	2,493	643.56	236.61	-	2.11